Compare WEX & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WEX | NOVT |
|---|---|---|
| Founded | 1983 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.7B |
| IPO Year | 2004 | 1999 |
| Metric | WEX | NOVT |
|---|---|---|
| Price | $165.05 | $148.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $170.18 | $144.00 |
| AVG Volume (30 Days) | ★ 610.6K | 530.3K |
| Earning Date | 04-22-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.93 | N/A |
| EPS | ★ 2.22 | 0.51 |
| Revenue | ★ $2,660,800,000.00 | $521,290,000.00 |
| Revenue This Year | $4.93 | $8.61 |
| Revenue Next Year | $4.55 | $6.57 |
| P/E Ratio | ★ $73.96 | $292.16 |
| Revenue Growth | 1.24 | ★ 35.49 |
| 52 Week Low | $125.29 | $98.27 |
| 52 Week High | $186.86 | $171.85 |
| Indicator | WEX | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 69.11 | 44.84 |
| Support Level | $145.44 | $147.74 |
| Resistance Level | $165.13 | $149.42 |
| Average True Range (ATR) | 5.70 | 7.79 |
| MACD | 2.35 | -1.22 |
| Stochastic Oscillator | 95.14 | 24.86 |
WEX Inc is a commerce platform that provides seamlessly embedded, personalized payments solutions. The company operates three business segments: Mobility, Benefits, and Corporate Payments. Mobility segment, the top segment by revenue, provides fleet vehicle payment solutions, transaction processing, and information management services for commercial and government fleets. The Corporate Payments segment offers business-to-business payment processing and transaction monitoring services. The Benefits segment generates revenue from healthcare payment products and its consumer-directed software platform. Its prime end market is the United States of America.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.